Custom Pricing and Contracting Studies

Key Results

12 Months Pre-Launch
Custom Payer Research Informed Optimal Pricing and Contracting Strategies
icon

Challenge

The pharma company’s market access team had difficulty identifying the optimal pricing strategy for its upcoming drug launch. It needed an in-depth outlook on anticipated formulary access and utilization and a view into payers’ perceptions of value.

icon

Solution

The organization partnered with MMIT to collaborate on a market research survey to answer key questions such as the net price threshold and corresponding formulary placement, and average rebates and discounts received by payers for products of interest.

Outcome

Armed with MMIT’s custom pricing and contracting study, the pharma company was able to predict payer response to its pricing strategy and set WAC price and appropriate rebates to maximize payer uptake.

FAQ

How can pharmaceutical companies determine the optimal drug launch pricing strategy?

Pharmaceutical companies can use custom pricing and contracting research to evaluate payer price sensitivity, anticipated formulary access, and potential rebate requirements before launching a new therapy. MMIT’s custom research combines quantitative payer surveys with pricing analysis methodologies, including Van Westendorp Price Sensitivity Analysis, to help manufacturers identify optimal price points and develop informed contracting strategies.

How did MMIT's custom pricing and contracting study help the pharmaceutical company prepare for launch?

MMIT partnered with the manufacturer’s market access team 12 months before launch to conduct quantitative payer research evaluating wholesale acquisition cost, rebate scenarios, and anticipated formulary placement. The study helped identify net price thresholds and payer discount expectations, enabling the company to predict payer responses and establish WAC pricing and appropriate rebates to maximize anticipated payer uptake.

What are the benefits of evaluating payer price sensitivity and rebate scenarios before a pharmaceutical launch?

Evaluating payer price sensitivity and rebate scenarios helps pharmaceutical manufacturers understand how pricing decisions may influence formulary placement, coverage restrictions, and payer adoption. MMIT’s Custom Pricing and Contracting Studies provide insights into payer perceptions of value, net price thresholds, and contracting expectations, supporting more informed launch pricing decisions and market access planning.

Answer Your Top Market Access Questions

MMIT’s Custom Pricing and Contracting Studies delivers a strategic and rigorous market research report incorporating a Van Westendorp Price Sensitivity Analysis along with recommendations to inform the optimal price point.
EXPLORE CUSTOM MARKET RESEARCH

Access the Latest

Real Challenges. Proven Solutions.

Discover how life sciences organizations are overcoming market access challenges, optimizing strategies, and driving measurable results with MMIT’s latest case studies.

Stay In Touch

Be the first to know about new arrivals and promotions

NEW RELEASE: The State of Patient Access 2026